Skip to content

Clinical trials

Withdrawn Pleural Effusion, Malignant trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pleural Effusion, Malignant Status: Withdrawn Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20181
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Case Comprehensive Cancer Center1
Genzyme, a Sanofi Company1
National Cancer Institute (NCI)1
Travera Inc1
Yale University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pleural Effusion, Malignant5
Carcinoma2
Carcinoma, Non-Small-Cell Lung2
Lung Neoplasms2
Neoplasm Metastasis2
Ovarian Neoplasms2
Small Cell Lung Carcinoma2
Anus Neoplasms1
Appendiceal Neoplasms1
Breast Neoplasms1

Trials

Showing 76 to 5 of 5. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.